Skip to main content
. 2022 Mar 16;13:813732. doi: 10.3389/fimmu.2022.813732

Figure 2.

Figure 2

Multivariate analyses of treatment lines, CPS level, 11q13 amplification, EGFR mutation, EGFR amplification, and age with progression-free survival. CPS and 11q13 amplification are independent factor affecting progression-free survival.